You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VERA Award Disclosure
Boman Nancy Lee · SEC Form 4 · Filed Aug 5, 2026
Award
Calculated transaction value
$0
Boman Nancy Lee Chief Regulatory Officer
VERA
Vera Therapeutics
VERA
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
VERA daily price context
Close on/before transaction
$32.23
Aug 3, 2026
First close after public filing
$32.02
Aug 6, 2026
30-day return after filing
+12.09%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 44,987 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002145711-26-000002
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vera Therapeutics, Inc. VERA Current | Award | Aug 3, 2026 | $0 |
| Vera Therapeutics, Inc. VERA | Award | Aug 3, 2026 | $0 |